Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2924)
All Articles published online
|
Publishing Process of This Article
|
Sep 9, 2025 (publication date) through Feb 3, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Pediatrics
ISSN
2219-2808
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Rehman R. Role of glucagon-like peptide-1 receptor agonists in pediatric obesity and metabolic dysfunction associated steatotic liver disease. World J Clin Pediatr 2025; 14(3): 105731 [PMID: 40881096 DOI: 10.5409/wjcp.v14.i3.105731] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Rehman R. Role of glucagon-like peptide-1 receptor agonists in pediatric obesity and metabolic dysfunction associated steatotic liver disease. World J Clin Pediatr 2025; 14(3): 105731 [PMID: 40881096 DOI: 10.5409/wjcp.v14.i3.105731] |
|---|---|
| URL: | https://www.wjgnet.com/2219-2808/full/v14/i3/105731.htm |
| Number | Citing Articles |
| 1 |
Hua Wen. Beyond lifestyle modification: the role of GLP-1 receptor agonists in treating pediatric obesity. Frontiers in Pediatrics 2026; 13 doi: 10.3389/fped.2025.1684485
|